267 related articles for article (PubMed ID: 31898792)
1. Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases.
Andrejew R; Glaser T; Oliveira-Giacomelli Á; Ribeiro D; Godoy M; Granato A; Ulrich H
Adv Exp Med Biol; 2019; 1201():275-353. PubMed ID: 31898792
[TBL] [Abstract][Full Text] [Related]
2. Purinergic receptors in embryonic and adult neurogenesis.
Oliveira Á; Illes P; Ulrich H
Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
[TBL] [Abstract][Full Text] [Related]
3. The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators.
Pan L; Ma Y; Li Y; Wu H; Huang R; Cai Z; Wu X
Mini Rev Med Chem; 2021; 21(11):1288-1302. PubMed ID: 33302833
[TBL] [Abstract][Full Text] [Related]
4. Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2.
Dos Anjos F; Simões JLB; Assmann CE; Carvalho FB; Bagatini MD
J Immunol Res; 2020; 2020():8632048. PubMed ID: 33299899
[TBL] [Abstract][Full Text] [Related]
5. More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease.
Wernly B; Zhou 周稚超 Z
Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H723-H729. PubMed ID: 32822211
[TBL] [Abstract][Full Text] [Related]
6. Tackling Chronic Pain and Inflammation through the Purinergic System.
Magni G; Riccio D; Ceruti S
Curr Med Chem; 2018; 25(32):3830-3865. PubMed ID: 28699505
[TBL] [Abstract][Full Text] [Related]
7. Purinergic Signaling and its Role in the Stem Cell Differentiation.
Zaib S; Areeba ; Khan I
Mini Rev Med Chem; 2024; 24(8):863-883. PubMed ID: 37828668
[TBL] [Abstract][Full Text] [Related]
8. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
9. Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration.
Tóth A; Antal Z; Bereczki D; Sperlágh B
Neurochem Res; 2019 Oct; 44(10):2413-2422. PubMed ID: 31054067
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.
Glaser T; Cappellari AR; Pillat MM; Iser IC; Wink MR; Battastini AM; Ulrich H
Purinergic Signal; 2012 Sep; 8(3):523-37. PubMed ID: 22143354
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signaling in diabetes and metabolism.
Jain S; Jacobson KA
Biochem Pharmacol; 2021 May; 187():114393. PubMed ID: 33359363
[TBL] [Abstract][Full Text] [Related]
12. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
13. Purinergic receptors in psychiatric disorders.
Krügel U
Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
[TBL] [Abstract][Full Text] [Related]
14. Purinergic Mechanisms and Pain.
Burnstock G
Adv Pharmacol; 2016; 75():91-137. PubMed ID: 26920010
[TBL] [Abstract][Full Text] [Related]
15. Targeting Adenosine Receptors in Neurological Diseases.
Atif M; Alsrhani A; Naz F; Imran M; Imran M; Ullah MI; Alameen AAM; Gondal TA; Raza Q
Cell Reprogram; 2021 Apr; 23(2):57-72. PubMed ID: 33861641
[TBL] [Abstract][Full Text] [Related]
16. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
17. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.
Antonioli L; Blandizzi C; Pacher P; Haskó G
Pharmacol Rev; 2019 Jul; 71(3):345-382. PubMed ID: 31235653
[TBL] [Abstract][Full Text] [Related]
18. How to influence the mesenchymal stem cells fate? Emerging role of ectoenzymes metabolizing nucleotides.
Roszek K; Wujak M
J Cell Physiol; 2018 Jan; 234(1):320-334. PubMed ID: 30078187
[TBL] [Abstract][Full Text] [Related]
19. Role of purines in brain development, from neuronal proliferation to synaptic refinement.
Rimbert S; Moreira JB; Xapelli S; Lévi S
Neuropharmacology; 2023 Oct; 237():109640. PubMed ID: 37348675
[TBL] [Abstract][Full Text] [Related]
20. Purinergic Signaling Regulates the Transforming Growth Factor-β3-Induced Chondrogenic Response of Mesenchymal Stem Cells to Hydrostatic Pressure.
Steward AJ; Kelly DJ; Wagner DR
Tissue Eng Part A; 2016 Jun; 22(11-12):831-9. PubMed ID: 27137792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
